Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fulvestrant (Atc Code: L02Ba03).

Name: Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fulvestrant (Atc Code: L02Ba03).
Start: 2023-04-08
End: 2025-03-27
Location: AOK Lower Saxony. The health insurance.

AOK Lower Saxony. The health insurance. Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fulvestrant (Atc Code: L02Ba03). in Pharmaceuticals. The tender was released on Apr 07, 2023.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fulvestrant (Atc Code: L02Ba03).

Deadline - Mar 27, 2025

GT reference number - 64543010

Product classification - Endocrine therapy medicinal products

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 64543010

Document Type - Tender Notices

Notice Details and Documents:

Description - Conclusion of a non-exclusive discount contract according to Section 130a Paragraph 8 SGB V for medicinal products with the active substance fulvestrant (ATC code: L02BA03) within the period from June 1st, 2023 to May 31st, 2025 with the possibility of concluding the contract at any time during the term ("open- house model").

Gt Ref Id - 64543010

Deadline - Mar 27, 2025

View more tenders for

Pharmaceuticals Tenders Endocrine therapy medicinal pr Tenders Germany Tenders

Similar Tenders :

Create Account

Join to access thousands of business opportunities

Quick Links

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database